Todd C Davis insider trades
Open-market stock purchases and sales by Todd C Davis, Director at Pelthos Therapeutics Inc, from SEC Form 4 filings since May 29, 2009.
Track record: 86% of 7 scored buys are up 5% or more since purchase, averaging +121%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | PTHS Pelthos Therapeutics Inc | Bought | $986K |
| Jun 11, 2026 | PTHS Pelthos Therapeutics Inc | Bought | $14.4K |
| Jun 10, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | — |
| Mar 2, 2026 | LGND Ligand Pharmaceuticals Inc | Bought (not open market) | — |
| Mar 2, 2026 | LGND Ligand Pharmaceuticals Inc | Bought (not open market) | — |
| Feb 15, 2026 | LGND Ligand Pharmaceuticals Inc | Sold (not open market) | $375K |
| Feb 15, 2026 | LGND Ligand Pharmaceuticals Inc | Sold (not open market) | $782K |
| Feb 15, 2026 | LGND Ligand Pharmaceuticals Inc | Sold (not open market) | $516K |
| Feb 14, 2026 | LGND Ligand Pharmaceuticals Inc | Bought (not open market) | — |
| Feb 14, 2026 | LGND Ligand Pharmaceuticals Inc | Sold (not open market) | $1.5M |
| Feb 14, 2026 | LGND Ligand Pharmaceuticals Inc | Bought (not open market) | — |
| Feb 14, 2026 | LGND Ligand Pharmaceuticals Inc | Sold (not open market) | $2.9M |
| Dec 4, 2025 | LGND Ligand Pharmaceuticals Inc | Sold (not open market) | — |
Companies traded
- PTHS Pelthos Therapeutics Inc: 2 buys, last Jun 11, 2026
- PVLA Palvella Therapeutics, Inc: other filings, last Jun 10, 2026
- LGND Ligand Pharmaceuticals Inc: 7 buys, 8 sales, last Mar 2, 2026
- CHRO Chromocell Therapeutics Corp: other filings, last Nov 13, 2024
- VXRT Vaxart, Inc: 1 sale, last Aug 4, 2022
- BDSI Biodelivery Sciences International Inc: 2 sales, last Mar 22, 2022